Ac immune reports first quarter 2021 financial results and provides corporate update

Lausanne, switzerland, april 28, 2021 (globe newswire) -- ac immune sa (nasdaq: aciu), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today reported its financial results for the quarter ended march 31, 2021. the company also provided an overview of its recent clinical and corporate highlights and anticipated milestones for 2021.
ACIU Ratings Summary
ACIU Quant Ranking